Journal of Hepatology
Volume 53, Issue 2 , Pages 283-290 , August 2010

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

  • Florence Wong

      Affiliations

    • Department of Medicine, University of Toronto, Canada
    • Corresponding Author InformationCorresponding author. Address: 9th floor, North Wing, Room 983, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada M5G2C4. Tel.: +1 416 340 3834; fax: +1 416 340 5019.
    • ,
  • Pere Gines

      Affiliations

    • Hospital Clinic, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Catalunya, Spain
    • ,
  • Hugh Watson

      Affiliations

    • Internal Medicine, Clinical Development, Sanofi-Aventis R&D, Chilly-Mazarin, France
    • ,
  • Yves Horsmans

      Affiliations

    • Saint-Luc University Hospital, Brussels, Belgium
    • ,
  • Paolo Angeli

      Affiliations

    • University of Padova, Italy
    • ,
  • Paul Gow

      Affiliations

    • Austin Hospital, University of Melbourne, Australia
    • ,
  • Pascal Minini

      Affiliations

    • Internal Medicine, Clinical Development, Sanofi-Aventis R&D, Chilly-Mazarin, France
    • ,
  • Mauro Bernardi

      Affiliations

    • Department of Internal Medicine, University of Bologna, Italy

Received 17 January 2010 ,Revised 22 February 2010 ,Accepted 23 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The study was registered on a public clinical trial registry website, www.ClinicalTrials.org, number NCT 00501384.

PII: S0168-8278(10)00381-8

doi: 10.1016/j.jhep.2010.02.036

Journal of Hepatology
Volume 53, Issue 2 , Pages 283-290 , August 2010

Article Tools

* Image Usage & Resolution